Early platelet activation, inflammation and acute brain injury after a subarachnoid hemorrhage: a pilot study.
J A
JA
Frontera
L
L
Aledort
E
E
Gordon
N
N
Egorova
H
H
Moyle
A
A
Patel
J B
JB
Bederson
F
F
Sehba
D018806:APACHE; D000704:Analysis of Variance; D015415:Biomarkers / Q000097:blood; D001930:Brain Injuries / Q000097:blood / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology; D002097:C-Reactive Protein / Q000378:metabolism; D004185:Disability Evaluation; D005338:Fibrin Fibrinogen Degradation Products / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology; D018836:Inflammation Mediators / Q000097:blood; D016015:Logistic Models; D009519:New York City; D016017:Odds Ratio; D010865:Pilot Projects; D015539:Platelet Activation; D011379:Prognosis; D011446:Prospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D013345:Subarachnoid Hemorrhage / Q000097:blood / Q000150:complications* / Q000175:diagnosis / Q000276:immunology; D013916:Thrombelastography; D013997:Time Factors; D015854:Up-Regulation
D015415:Biomarkers; D005338:Fibrin Fibrinogen Degradation Products; D018836:Inflammation Mediators; C036309:fibrin fragment D; D005340:Fibrinogen; D002097:C-Reactive Protein